- Home
- NPCT vs CLPT Comparison
NPCT vs CLPT Comparison
Compare NPCT & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCT
- CLPT
- Stock Information
- Founded
- NPCT 2020
- CLPT 1998
- Country
- NPCT United States
- CLPT United States
- Employees
- NPCT N/A
- CLPT N/A
- Industry
- NPCT Investment Managers
- CLPT Medical/Dental Instruments
- Sector
- NPCT Finance
- CLPT Health Care
- Exchange
- NPCT Nasdaq
- CLPT Nasdaq
- Market Cap
- NPCT 313.7M
- CLPT 317.4M
- IPO Year
- NPCT N/A
- CLPT N/A
- Fundamental
- Price
- NPCT $10.91
- CLPT $10.49
- Analyst Decision
- NPCT
- CLPT Strong Buy
- Analyst Count
- NPCT 0
- CLPT 3
- Target Price
- NPCT N/A
- CLPT $27.67
- AVG Volume (30 Days)
- NPCT 107.1K
- CLPT 375.5K
- Earning Date
- NPCT 01-01-0001
- CLPT 08-12-2025
- Dividend Yield
- NPCT 9.82%
- CLPT N/A
- EPS Growth
- NPCT N/A
- CLPT N/A
- EPS
- NPCT N/A
- CLPT N/A
- Revenue
- NPCT N/A
- CLPT $33,593,000.00
- Revenue This Year
- NPCT N/A
- CLPT $22.34
- Revenue Next Year
- NPCT N/A
- CLPT $25.50
- P/E Ratio
- NPCT N/A
- CLPT N/A
- Revenue Growth
- NPCT N/A
- CLPT 19.68
- 52 Week Low
- NPCT $8.58
- CLPT $9.76
- 52 Week High
- NPCT $10.63
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- NPCT 48.99
- CLPT 44.46
- Support Level
- NPCT $10.82
- CLPT $10.42
- Resistance Level
- NPCT $10.98
- CLPT $10.88
- Average True Range (ATR)
- NPCT 0.12
- CLPT 0.52
- MACD
- NPCT -0.01
- CLPT -0.01
- Stochastic Oscillator
- NPCT 48.15
- CLPT 22.75
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.